In Vivo · 2020 · 23 citations · 25 references
MedicineMolecular MedicineObstetricsHigh-risk PregnancyMaternal-fetal MedicineReproductive ImmunologyEclampsiaMicrorna BiologyPregnancyPregnancy ImmunologyBiomarkers Of PreeclampsiaEarly Detection Of PreeclampsiaGene Ontology AnalysisPreeclampsia PathophysiologyPreeclampsia Risk PredictionQuantitative Polymerase Chain ReactionReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction Assays
BACKGROUND/AIM: To characterize global microRNA (miRNA) expression profile in the first trimester maternal plasma of women who subsequently develop late-onset preeclampsia (LOPE) compared to uncomplicated pregnancies. MATERIALS AND METHODS: Five first trimester plasma samples from women who developed LOPE and 5 controls were analyzed using next generation sequencing technology (NGS) followed by target prediction, Gene Ontology analysis and pathway identification. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed for confirmation in an independent cohort of 12 LOPE cases and 12 controls. RESULTS: miR-23b-5p and miR-99b-5p were down-regulated by >1.5 fold in LOPE complicated pregnancies (p value <0.05) compared to controls. Target prediction showed that the major targets of these miRNAs are associated with glycometabolism and immune response. CONCLUSION: miR-23b-5p and miR-99b-5p are possibly implicated in the pathogenic mechanisms leading to the induction of LOPE and may serve as candidate non-invasive biomarkers for early prediction and prevention.
25
Obstetrics and Gynecology · 2013 · 3.9K citations
Medicine, Gynecology, Obstetrics +9
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik, D. Wright, Liona C. Poon et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text